Innovo's G2-Cell Chip technology allows the researchers to study these specific effects on the drug target and other pathways in a novel way that no other present day technologies can. There are many genome wide screening systems but none of them can be used as a High Throughput Screening systems. Our G2-Cell Chip technology allows to perform Target Validation in a HTS system.

Good drugs are potent and specific; that is, they must have strong effects on a specific biological pathway and minimal effects on all other pathways. Confirmation that a compound inhibits the intended target (drug target validation) and the identification of undesirable secondary effects are among the main challenges in developing new drugs. In the modern drug discovery paradigm, which typically begins with the selection of a single molecular target, the ideal inhibitory drug is one that inhibits a single gene product so completely and so specifically that it is as if the gene product were absent. Treating cells with such a drug should induce changes in gene expression very similar to those resulting from deleting the gene encoding the drug’s target.